Targeting oxidative phosphorylation as an approach for the treatment of ovarian cancer

Yinjie Wu1, Xuewei Zhang1, Ziyi Wang2

  • 1Department of Gynecology, The First Affiliated Hospital of China Medical University, Shenyang, China.

Frontiers in Oncology
|September 23, 2022
PubMed

Insights

Ovarian cancer cells alter oxidative phosphorylation for survival. Targeting this metabolic pathway offers a promising strategy for new anti-cancer treatments against this lethal gynecological malignancy.

Area of Science:

  • Oncology
  • Cancer Metabolism
  • Gynecologic Oncology

Background:

  • Ovarian cancer is a leading cause of cancer death in women.
  • Tumor cells exhibit metabolic adaptation, reprogramming pathways for growth and survival.
  • Oxidative phosphorylation is a key metabolic process altered in various cancers.

Purpose of the Study:

  • To provide an overview of oxidative phosphorylation in cancer.
  • To discuss the role of oxidative phosphorylation in ovarian cancer and its chemotherapeutic resistance.
  • To explore the impact of oxidative phosphorylation on the ovarian cancer tumor microenvironment.

Main Methods:

  • Literature review and synthesis of existing research on oxidative phosphorylation in cancer.
  • Analysis of the role of oxidative phosphorylation in ovarian cancer progression and drug resistance.
  • Examination of oxidative phosphorylation's influence on the tumor microenvironment.

Main Results:

  • Oxidative phosphorylation is significantly altered in ovarian cancer cells.
  • Dysregulated oxidative phosphorylation contributes to ovarian cancer's aggressive nature and resistance to chemotherapy.
  • Oxidative phosphorylation impacts various components within the ovarian cancer tumor microenvironment.

Conclusions:

  • Altered oxidative phosphorylation represents a critical metabolic vulnerability in ovarian cancer.
  • Targeting oxidative phosphorylation presents a promising therapeutic strategy for ovarian cancer treatment.
  • Further research into oxidative phosphorylation's role could lead to more effective anti-cancer regimens.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
14.9K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K